ACM
HARP

Altium Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Altium Capital Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,961
Closed -$4.18M – 162
2021
Q1 		$4.18M Buy
19,961
+9,762
+96% +$1.96M 1.16% 29
2020
Q4 		$1.69M Buy
+10,199
New +$1.58M 0.63% 73

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Altium Capital Management's HARP Position: Q2 2021 in Review

Altium Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 19,961 shares — an estimated $4.18M sold.

Altium Capital Management first reported a position in HARP in Q4 2020 and held it in 2 quarters. The position peaked at $4.18M in Q1 2021. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Altium Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Altium Capital Management sold 19,961 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $4.18M.
  • Altium Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Altium Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.18M in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Altium Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.